Prompting patients to keep tabs on their blood pressure at home can reduce their risk of heart attack, stroke and heart disease, a new study says.

People were 34% less likely to be hospitalized or die from heart attack, stroke or heart failure if they self-monitored their blood pressure at home and shared the readings with their doctors.Full Page

A family’s financial situation has more impact on their children’s brain development than parenting style, a new study says.

Family finances and opportunities in a child’s neighborhood account for about 16% of the variability in kids’ brain function — far more than IQ, health history or how their parents raise... Full Page

Folks losing weight on Ozempic or Zepbound tend to start slacking off when it comes to exercise, a new study says.

People’s daily step count and physical activity declined after starting a GLP-1 medication, researchers reported Saturday at the Endocrine Society’s annual meeting in Chicago.

“While many assume that we... Full Page

The U.S. Food and Drug Administration (FDA) is investigating a multistate outbreak of infant botulism linked to Nara Organics Whole Milk Organic Powdered Infant Formula.

Three infants in California, Pennsylvania and Washington have been diagnosed with toxin type A infections after consuming formula in April or May.

Nara Organics Powd... Full Page

The U.S. Food and Drug Administration (FDA) has cleared the first over-the-counter wearable device to track blood sugar in young children.

The continuous glucose monitor (CGM) — called the Stelo Glucose Biosensor System — is for use in children as young as 2 years old who do not use insulin.

This marks the first time a CG... Full Page

Folks are told that once you start taking Ozempic or Zepbound, you’ll need to stay on them to maintain the drugs’ benefits.

But patients prescribed such GLP-1 drugs are more likely to stop them and then restart use later than was previously assumed, according to research presented Sunday at the Endocrine Society’s annual ... Full Page